Respiratory disease
Home / Products / Rapid Test Kit / Respiratory disease / SARS-COV-2&Influenza A/B Antigen Combo Rapid Test Kit

SARS-COV-2&Influenza A/B Antigen Combo Rapid Test Kit

SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit (LFIA) is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of SARS-CoV-2 Influenza A/Influenza B virus antigen in anterior nasal swabs.
Contact Us
Product Features
1.Convenience
-- Easy to operate
-- One test for three results
2.Accuracy
SARS-CoV-2 Flu A/B
Sensitivity 86.46% 91.96%
Specificity 100.00% 100.00%
Accuracy 97.80% 98.72%
3.Fast:
-- Read the results within 1 5mins
4.Painless:
-- No uncomfortable feeling for nasopharyngeal swab sampling.
Compatible head: Universal
REF Specification
1041-14-01 1pc/Box
1041-24-01 2pcs/Box
1041-34-01 5pcs/Box
1041-54-01 20pcs/Box
Feedback
Send
Zhejiang Wantaifu Biotechnology Co., Ltd.
Zhejiang Wantaifu Biotechnology Co., Ltd., established in 2022, is now located in Hangzhou Bay Life Science Park, Economic and Technological Development Zone, Xiaoshan District, Hangzhou. It is an integrated innovative enterprise.

we are China wholesale SARS-COV-2&Influenza A/B Antigen Combo Rapid Test Kit manufacturers and OEM SARS-COV-2&Influenza A/B Antigen Combo Rapid Test Kit factory. The production center has 100,000-level automatic production lines, which provide effective guarantee for the high precision and high efficiency of products, convenient for customers to do flexible customization, design and processing of precision consumables.

Who

we are

30 Million
Registered capital
130 +
Employees
2022
was founded in
100 Million
Total investment
Our Latest News and Exhibitions
honor